-
Signature
-
/s/ Matthew Meziere as attorney-in-fact
-
Issuer symbol
-
BLBD
-
Transactions as of
-
17 Dec 2025
-
Net transactions value
-
-$274,845
-
Form type
-
4
-
Filing time
-
17 Dec 2025, 15:50:47 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Radulescu Razvan |
Chief Financial Officer |
3920 ARKWRIGHT ROAD, SUITE 200, MACON |
/s/ Matthew Meziere as attorney-in-fact |
17 Dec 2025 |
0001884757 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BLBD |
Common Stock, par value $0.0001 |
Options Exercise |
$43,262 |
+3,503 |
+7.6% |
$12.35 |
49,683 |
17 Dec 2025 |
Direct |
|
| transaction |
BLBD |
Common Stock, par value $0.0001 |
Options Exercise |
$43,262 |
+3,503 |
+7.1% |
$12.35 |
53,186 |
17 Dec 2025 |
Direct |
|
| transaction |
BLBD |
Common Stock, par value $0.0001 |
Sale |
$361,369 |
-7,006 |
-13% |
$51.58 |
46,180 |
17 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BLBD |
Stock Option (right to buy) |
Options Exercise |
$0 |
-3,503 |
-100% |
$0.000000 |
0 |
17 Dec 2025 |
Common Stock, par value $0.0001 |
3,503 |
$12.35 |
Direct |
|
| transaction |
BLBD |
Stock Option (right to buy) |
Options Exercise |
$0 |
-3,503 |
-100% |
$0.000000 |
0 |
17 Dec 2025 |
Common Stock, par value $0.0001 |
3,503 |
$12.35 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: